TROXELTA Trademark

Trademark Overview

On Friday, June 3, 2016, a trademark application was filed for TROXELTA with the United States Patent and Trademark Office. The USPTO has given the TROXELTA trademark a serial number of 87059084. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 16, 2019. This trademark is owned by Glaxo Group Limited. The TROXELTA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders
troxelta

General Information

Serial Number87059084
Word MarkTROXELTA
Filing DateFriday, June 3, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 16, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 20, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders
Translation of Words in MarkThe wording "TROXELTA" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 10, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Wednesday, November 9, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 9, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 9, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, December 16, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 16, 2019ABANDONMENT - NO USE STATEMENT FILED
Thursday, December 5, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 5, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, May 16, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 15, 2019SOU EXTENSION 5 GRANTED
Thursday, May 9, 2019SOU EXTENSION 5 FILED
Wednesday, May 15, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, May 9, 2019TEAS EXTENSION RECEIVED
Saturday, October 20, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 18, 2018SOU EXTENSION 4 GRANTED
Thursday, October 18, 2018SOU EXTENSION 4 FILED
Thursday, October 18, 2018TEAS EXTENSION RECEIVED
Friday, May 4, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 2, 2018SOU EXTENSION 3 GRANTED
Wednesday, May 2, 2018SOU EXTENSION 3 FILED
Wednesday, May 2, 2018TEAS EXTENSION RECEIVED
Tuesday, October 10, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 6, 2017SOU EXTENSION 2 GRANTED
Friday, October 6, 2017SOU EXTENSION 2 FILED
Friday, October 6, 2017TEAS EXTENSION RECEIVED
Wednesday, May 17, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 15, 2017SOU EXTENSION 1 GRANTED
Monday, May 15, 2017SOU EXTENSION 1 FILED
Monday, May 15, 2017TEAS EXTENSION RECEIVED
Tuesday, November 15, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 20, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 20, 2016PUBLISHED FOR OPPOSITION
Wednesday, August 31, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, August 11, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 11, 2016ASSIGNED TO EXAMINER
Friday, June 10, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, June 7, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

troxelta disorders treatment pharmaceutical preparations substances diseases system related immune dermatological